Example: Heart Attack

Search clinical trials for: Cefepime

Total 67 results

NCT04278404

Recruiting

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

Conditions: Coronavirus Infection (COVID-19); Pulmonary Arterial Hypertension; Urinary Tract Infections in Children; Hypertension; Pain; Hyperphosphatemia; Primary Hyperaldosteronism; Edema; Hypokalemia; Heart Failure; Hemophilia; Menorrhagia; Insomnia; Pneumonia; Skin Infection; Arrythmia; Asthma in Children; Bronchopulmonary Dysplasia; Adrenal Insufficiency; Fibrinolysis; Hemorrhage; Attention Deficit Hyperactivity Disorder; Multisystem Inflammatory Syndrome in Children (MIS-C); Kawasaki Disease; Coagulation Disorder; Down Syndrome
NCT04250038

Recruiting

Association of Cefepime Trough Levels With Clinical Efficacy and Neurotoxicity in Patients With Febrile Neutropenia

Conditions: Pharmacokinetics; Pharmacodynamics; Cefepime
NCT04233996

Recruiting

Efficacy of Extended Infusion of β-lactam Antibiotics for the Treatment of Febrile Neutropenia in Hematologic Patients

Conditions: Febrile Neutropenia
NCT04187755

Completed

Cefepime vs Ceftazidime as Empirical Therapy for Neutropenic Fever

Conditions: Neutropenia, Febrile; Leukemia; Pediatric Cancer; Antibiotic Reaction
NCT04042233

Recruiting

Intraosseous Vancomycin in Primary Total Hip Arthroplasty - Designing a Protocol

Conditions: Prosthetic Joint Infection; Vancomycin; Joint Diseases
NCT04033029

Not yet recruiting

Antibiotic Plasma Concentrations During Continuous Renal Replacement Therapy With a High Adsorption Membrane (oXiris®)

Conditions: Hemodiafiltration; Sepsis; Acute Kidney Injury
NCT04009772

Recruiting

Single Dose Cefepime Versus Cefuroxime Plus Metronidazole as a Prophylactic Antibiotic During Emergency Intrapartum Cesarean Section

Conditions: Emergency Cesarean Section; Infection Wound
NCT04000711

Completed

Safety and Efficacy of Ambulatory Versus In-hospital Antibiotic Treatment in Children With Febrile Neutropenia

Conditions: Chemotherapy-Induced Febrile Neutropenia
NCT03960905

Recruiting

A Study the Population Pharmacokinetics of Children of Infectious Disease in Central Nervous System

Conditions: Central Nervous System Infection
NCT03897582

Recruiting

Beta-Lactams Dosing In Pneumonia in ICU in Patients Treated by Continuous Renal Replacement Therapy: the BLIPIC Study

Conditions: Beta-lactam; Continuous Renal Replacement Therapy; Pneumonia; Antibiotic
NCT03870490

Completed

Safety and Pharmacokinetics of VNRX-5133 in the Epithelial Lining Fluid of Healthy Adult Subjects

Conditions: Healthy Subjects
NCT03850860

Completed

Comparison of Two Empirical Antimicrobial Therapies of Prosthetic Joint Infection

Conditions: Bone and Joint Infection
NCT03840148

Recruiting

Safety and Efficacy Study of Cefepime/VNRX-5133 in Patients With Complicated Urinary Tract Infections

Conditions: Urinary Tract Infections; Acute Pyelonephritis
NCT03790631

Recruiting

The OPTIMAL TDM Study: Determining Optimal Beta-lactam Plasma Concentrations Through Therapeutic Drug Monitoring

Conditions: Beta-lactam Antibiotics; Therapeutic Drug Monitoring; Toxicity; Efficacy; Imipenem; Meropenem; Piperacillin; Flucloxacillin; Amoxicillin; Ceftazidime; Cefepime
NCT03687255

Completed

Safety and Efficacy Study of Cefepime-AAI101 in the Treatment of Complicated Urinary Tract Infections

Conditions: Urinary Tract Infections
NCT03685084

Completed

Investigation of AAI101 Safety, Tolerability & PK in Healthy Volunteers

Conditions: Healthy
NCT03680352

Recruiting

Pharmacokinetics of Cefepime and AAI101 in Subjects With Renal Insufficiency and Healthy Subjects

Conditions: PK in Patients With Various Degrees of Renal Impairment
NCT03680378

Completed

Lung Pharmacokinetics (PK) in Epithelial Lining Fluid (ELF)

Conditions: Healthy Subjects
NCT03680612

Completed

Cefepime/AAI101 Phase 2 Study in Hospitalized Adults With cUTI

Conditions: Urinary Tract Infections
NCT03678142

Completed

DetectAB - Detecting Antibiotics

Conditions: Antibiotic Drug Concentration in Sweat
NCT03638830

Recruiting

Safety and Efficacy Study of Ftortiazinon in the Treatment of Patients With Complicated Urinary Tract Infections Caused by P. Aeruginosa

Conditions: Patients With Complicated Urinary Tract Infections Caused by P. Aeruginosa; Pseudomonas Aeruginosa; Pseudomonas Infections; Urinary Tract Infections
NCT03630081

Not yet recruiting

Study of Cefepime-tazobactam (FEP-TAZ) in Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)

Conditions: Complicated Urinary Tract Infection; Acute Pyelonephritis
NCT03630094

Completed

Plasma and Intrapulmonary Concentrations Study of WCK 5222

Conditions: PHA1A
NCT03622008

Completed

To Investigate the Multiple Dose Safety, Tolerability and Pharmacokinetics of WCK 4282 (FEP-TAZ)

Conditions: Antibiotics Causing Adverse Effects in Therapeutic Use
NCT03485950

Recruiting

Comparative Study To Determine The Efficacy, Safety, And Tolerability Of Ceftolozane-Tazobactam

Conditions: Other Infectious Diseases
NCT03409679

Terminated

Pivotal Study in VAP Suspected or Confirmed to be Due to Pseudomonas Aeruginosa

Conditions: Pneumonia
NCT03245879

Completed

Antibiotic Stewardship in Small Hospitals

Conditions: Inappropriate Prescribing; Antibiotic Stewardship; Anti-Bacterial Agents
NCT03147807

Unknown status

BetaLACTA® Test for Early De-escalation of Empirical Carbapenems in Pulmonary, Urinary and Bloodstream Infections in ICU

Conditions: Pneumonia; Urinary Tract Infections; Bloodstream Infection
NCT03078010

Recruiting

Choosing the Best Antibiotic to Protect Friendly Gut Bacteria During the Course of Stem Cell Transplant

Conditions: Intestinal Microbiome; Febrile Neutropenia
NCT02942810

Completed

To Investigate The Pharmacokinetics Of Intravenous WCK 5222 (FEP-ZID) In Patients With Renal Impairment

Conditions: Renal Impairment
NCT02872038

Completed

Comparing Cefepime Versus Cefazolin Plus Ceftazidime for CAPD-associated Peritonitis

Conditions: Peritoneal Dialysis Associated Peritonitis
NCT02820987

Unknown status

PK/PD of Extended-infusion Meropenem, Piperacillin-tazobactam and Cefepime in the Early Phase of Septic Shock

Conditions: Septic Shock
NCT02795949

Completed

Study on Reduced Antibiotic Treatment vs Broad Spectrum Betalactam in Patients With Bacteremia by Enterobacteriaceae

Conditions: Enterobacteriaceae Infections
NCT02732327

Terminated

Comparative Study of Ceftazidime-Avibactam Versus Standard of Care as Therapy in Febrile Neutropenic Adults With Cancer

Conditions: Neoplasms; Febrile Neutropenia
NCT02709382

Completed

A Single-dose Study to Investigate the Pharmacokinetics of Intravenous FEP-TAZ in Patients With Renal Impairment

Conditions: Renal Impairment
NCT02707107

Completed

MED Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Intravenous WCK 5222 (Zidebactam and Cefepime) in Healthy Volunteers

Conditions: Serious Gram-negative Infections
NCT02688582

Completed

Target-controlled Infusion Model for Cefepime

Conditions: Antimicrobial Treatment
NCT02680600

Completed

Individualized Cefepime Dosing Study

Conditions: Antimicrobial Treatment
NCT02581280

Completed

Population Pharmacokinetics of Teicoplanin, Levofloxacin, Piperacillin/Tazobactam, Meropenem, Vancomycin, Remifentanil, Cefepime, Cefpirome, Sufentanil, Midazolam, Clopidogrel, Ticagrelor, Prasugrel During Veno-arterial Extracorporeal Membrane Oxygenation (VA ECMO)

Conditions: Cardiac Dysfunction
NCT02568800

Unknown status

Prolonged Infusion Cefepime and Nosocomial Infections

Conditions: Urinary Tract Infection; Respiratory Tract Infection
NCT02532140

Completed

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of WCK 5107 Alone and in Combination With Cefepime

Conditions: Healthy
NCT02497781

Completed

Evaluation of Safety, Pharmacokinetics and Efficacy of Ceftazidime and Avibactam (CAZ-AVI ) Compared With Cefepime in Children From 3 Months to Less Than 18 Years of Age With Complicated Urinary Tract Infections (cUTIs)

Conditions: Complicated Urinary Tract Infections
NCT02458261

Completed

Pharmacokinetics and Pharmacodynamics of Extended-Infusion Cefepime in Continuous Renal Replacement Therapy

Conditions: Drug Mechanism
NCT02302092

Terminated

An Efficacy and Safety of Flomoxef Versus Cefepime in the Treatment of Participants With Urinary Tract Infections

Conditions: Urinary Tract Infection
NCT02168816

Terminated

Efficacy of Oral Antibiotic Therapy Compared to Intravenous Antibiotic Therapy for Osteomyelitis

Conditions: Osteomyelitis
NCT02123628

Completed

Antibiotic Treatment Duration for Non-Surgically-Treated Diabetic Foot Osteomyelitis

Conditions: Diabetes Mellitus
NCT02099240

Unknown status

Patients Response to Early Switch To Oral:Osteomyelitis Study

Conditions: Osteomyelitis
NCT01852630

Completed

Imipenem Versus Cefepime in Spontaneous Bacterial Peritonitis and to Evaluate the Risk Factors for Treatment Failure

Conditions: Spontaneous Bacterial Peritonitis
NCT01793012

Completed

Drug Monitoring of Antibiotics in Critical Care Patients

Conditions: ARDS; Sepsis
NCT01667094

Unknown status

A Study Comparing Continuous Infusion Antibiotics to Standard Treatment for Lung Infections in Cystic Fibrosis

Conditions: Cystic Fibrosis

Search clinical trials for: Cefepime

Recent CRA jobs

Scientist - BioAnalytics

Finance Assistant (6 months internship)

Digital Implementation Manager - eCOA (remote)

Sr CM Analyst I

Project Manager - Central Lab

Shipping/ Receiving Coordinator

Associate Scientist / Scientist - GMP , Pilot Plant , Small Molecule

Principal Database Programmer (UK, Spain, Romania, Poland, Ireland)

Global Category Sourcing Manager - Clinical Lab

Clinical Research Physician